Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Stage II or III multiple myeloma according to Durie and Salmon criteria.~* Patients between 65 and 75 years of age~* Previously untreated patients~Exclusion Criteria:~* Prior history of another neoplasm (except basocellular cutaneous or cervical epithelioma)~* Primary or associated amyloidosis~* World Health organisation performance index of at least 3~* Significant renal insufficiency with creatinine serum levels of 5.0 mg per deciliter or more~* Cardiac or hepatic dysfunction~* Cerebral circulatory insufficiency~* Absolute contraindication to corticosteroids~* Peripheral neuropathy~* HIV or hepatitis B or C positivity~* Patients who had geographic, social or psychological conditions which might prevent adequate follow-up

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).